Literature DB >> 4045717

Instructions control whether nicotine will serve as a reinforcer.

J R Hughes, R W Pickens, W Spring, R M Keenan.   

Abstract

Three studies examined self-administration of nicotine among exsmokers given concurrent access to nicotine (2 mg) and placebo gums during the first 2 weeks of abstinence from smoking. In Study 1 subjects were told they would receive either nicotine or placebo gum. With this instructional set, nicotine served as a reinforcer; i.e., subjects consistently self-administered nicotine but not placebo gum. However, subjects could discriminate gums on the basis of side-effects; thus, the ability of nicotine to serve as a reinforcer may have been due, not to its psychoactive effects, but rather because subjects believed the gum with more side-effects to be the active gum. In Study 2 we attempted to change this belief by telling subjects they would receive either the marketed nicotine gum or a new nicotine gum that is as effective as the marketed gum but has less side-effects (i.e., placebo). In Study 3 we attempted to change the belief by telling subjects that placebo gum had more side-effects than nicotine gum. With these two instructional sets, the stimulus properties of nicotine did not serve as reinforcer; i.e., subjects self-administered equal amounts of nicotine and placebo gums. To our knowledge, this is the first demonstration that instructions can control whether a drug will serve as a reinforcer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4045717

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

Review 1.  Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General.

Authors:  J W Cullen; W Blot; J Henningfield; G Boyd; R Mecklenburg; M M Massey
Journal:  Public Health Rep       Date:  1986 Jul-Aug       Impact factor: 2.792

2.  Marshaling the evidence for greater regulation and control of tobacco products: A call for action.

Authors:  R M Kaplan; C T Orleans; K A Perkins; J P Pierce
Journal:  Ann Behav Med       Date:  1995-03

3.  Perceived medication assignment during a placebo-controlled laboratory study of varenicline: temporal associations of treatment expectancies with smoking-related outcomes.

Authors:  John B Correa; Bryan W Heckman; Nicole S Marquinez; David J Drobes; Marina Unrod; Richard G Roetzheim; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

4.  Effect of instructions and nicotine on smoking cessation, withdrawal symptoms and self-administration of nicotine gum.

Authors:  J R Hughes; S B Gulliver; G Amori; G C Mireault; J F Fenwick
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Rule-governed behavior and human behavioral pharmacology: A brief commentary on an important topic.

Authors:  A Poling; M Lesage
Journal:  Anal Verbal Behav       Date:  1992

6.  Emotional reactivity to emotional and smoking cues during smoking abstinence: potentiated startle and P300 suppression.

Authors:  Jeffery M Engelmann; Jonathan C Gewirtz; Bruce N Cuthbert
Journal:  Psychophysiology       Date:  2011-12       Impact factor: 4.016

7.  Placebo responses to cocaine administration in humans: effects of prior administrations and verbal instructions.

Authors:  C Muntaner; N G Cascella; K M Kumor; C Nagoshi; R Herning; J Jaffe
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics.

Authors:  S J Leischow; D P Sachs; M D Hansen; A G Bostrom
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

9.  Human aggressive responding during acute tobacco abstinence: effects of nicotine and placebo gum.

Authors:  D R Cherek; R H Bennett; J Grabowski
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 10.  Do smokers self-administer pure nicotine? A review of the evidence.

Authors:  Reuven Dar; Hanan Frenk
Journal:  Psychopharmacology (Berl)       Date:  2004-03-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.